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Abstract
Objective-To investigate the relation between errors in calculation of gestational age and assessment of risk of Down's syndrome and to analyse the implications for screening programmes.
Design-Retrospective analysis of dating of gestational age by menstrual history v ultrasound scan. Computer program with maternal age and concentrations of a fetoprotein and free B human chorionic gonadotrophin to calculate risk for a range of expected dates of delivery. Computer simulated prospective application of new screening programme.
Setting-Teaching hospitals in Nottingham. Subjects-31 561 women with singleton pregnancies with gestational age based on routine ultrasound scan. Computer simulation of 20000 women in three age ranges (up to 37; up to 40; all).
Main outcome measures-Distribution of error between gestational age based on ultrasound scan v menstrual history. Proportion of women in the population who require precise dating of pregnancy; proportion ofwomen who require amniocentesis.
Results-With gestational age derived from ultrasound scan as reference the 95% confidence interval for gestational age by menstrual history was -27 to +9 days. A screening programme for Down's syndrome for women up to age 40 would yield a low risk (< 1:250) for this range of days in 86.0% of cases. The 14.0% of women remaining would have one or more high risk values in their report and would thus require an ultrasound scan for precise dating of the pregnancy; 30% of these-that is, 3.7% of the screened population-would be identified as high risk and require consideration for amniocentesis.
Conclusions-Screening programmes for Down's syndrome require the facility for precise dating of pregnancy to improve the accuracy of risk assessment. This can be achieved without introducing additional scans for early dating in the whole population but by selecting only those cases (about 14%) when an error in dates is likely to affect the risk ofDown's syndrome.
Introduction
Biochemical screening to determine the risk of Down's syndrome in all pregnancies has been advocated' and is being introduced in most health districts in the United Kingdom. 19 8 Ig/l age at delivery4 by an odds modifier based on a bivariate Gaussian frequency distribution5 by using published values for a fetoprotein and free I3 subunit of human chorionic gonadotrophin.6' The program can calculate expected date of delivery from the given last menstrual period and can print out a report with a range of expected delivery dates and corresponding values of risk of Down's syndrome.
We used data from 31 561 computer files of pregnancies dated by ultrasound from the Nottingham obstetric database to determine the frequency distribution for matemal age in this population. Of this dataset, 28755 files had complete menstrual records and were analysed to assess discrepancy between dating by menstrual history and ultrasonography before 20 weeks' gestation.
A computer simulation model was designed to test our risk programme and its implications for screening. Random numbers, generated with Wichman and Hill's algorithm,8 were used to obtain normally distributed z values according to the von Neuman rejection method.9 The z values were transformed according to published data7 to the appropriate, multiple of median concentrations for 13 human chorionic gonadotrophin and a fetoprotein specific for gestational age. Values for matemal age and when appropriate adjustments for gestational age were obtained as integers from our local cumulative frequency distribution. The output of each module was analysed with statistical software'" to ensure conformity with the published distributions. Each simulation was run for 20000 cases with an IBM compatible 486DX personal computer.
Results Figure 1 shows the discrepancy between gestational ages derived by ultrasonography and menstrual history in our population. For 21-5% of pregnancies scan dates were outside plus or minus 7 days from dates based on menstrual dates. The distribution was skewed: in 17-6% (that is, 82% of cases when the discrepancy was at least a week) the menstrual dates tended to overestimate the age of gestation. With ultrasonographic dating as reference, the 95% confidence interval for gestational age derived from menstrual history was -27 to +9 days. The median matemal age at booking in our population was 26 (interquartile range 22-29) years, and 7-2% of women were age 35 or over (fig 2) . Figure 3 shows the likelihood of Down's syndrome on a logarithmic axis plotted against a range of gestational ages for two illustrative samples ( 14 weeks, the risk of Down's syndrome would be < 1:1000 whereas at 18 weeks the odds would be > 1:100. For a given last menstrual period (here 1 April 1992) the program calculates the expected date of delivery (7 January 1993) plus a range of dates corresponding to the 95% confidence interval for menstrual dates (that is, -27 to + 9 days). Against each of these dates the risk of Down's syndrome is listed as a ratio. 14 This scan usually also serves to confirm or correct the expected date of delivery. The introduction of earlier scans to date each pregnancy for purposes of screening for Down's syndrome would still require the later scan to ensure reliable screening for structural anomalies. Even ultrasound dating may introduce error in risk assessment if weeks are rounded off and given as integers. '5 In our method this is avoided by calculating a whole range of gestational ages, representing the 95% confidence interval for date by menstrual history in this population, which are then expressed as a list of likely delivery dates. By determining the risk factor specific to gestation for each of these dates two possible categories are identified in which the report would be issued. For the overwhelming majority of cases the risk of Down's syndrome is low for the whole range of likely delivery dates. For example, if the screening programme includes all women under 40 and the agreed cut off for high risk is 1:250, 86% of women could be reassured by their general practitioner or community midwife as soon as the report is received without a dating scan having been performed (table II) . The remaining 14% of reports will have at least one high risk value for the given range of dates, and only these women will require early referral for a dating scan. These women need not be alarmed but told that the correct gestational age needs to be established before the risk for Down's syndrome can be read with any accuracy. This approach is justified as only 3-7% of these 14% of cases (table II) -that is, less than a third -will actually end up with a high risk value adjusted for gestational age and would be offered amniocentesis.
Our predicted rates of amniocenteses are similar to those which were obtained in two recent demonstration projects.' 16 But all cases in our system would be identified with the benefit of dates adjusted by scan. We believe that this method will increase the detection rate of Down's syndrome, a hypothesis which we intend to test prospectively.
On the report the risk of Down's syndrome can be printed out categorically as high and low or expressed as a numerical likelihood ratio, which clinicians may prefer for purposes of counselling. Figure 4 gives an example of a possible format in which a computer report could be issued. If the dates have to be revised after the scan there is no need to refer back to the laboratory as the clinician will usually find the new risk value within the range of dates listed on the report.
In 5% of all cases the actual gestational age will by definition fall outside our stated confidence interval for menstrual dates. In cases when the error is towards overestimation of the actual gestation no high risk patients would be missed as the risk values within the reported range would also be high, thus already indicating early referral for a dating scan. At the other extreme, for the 2-5% of women with a grossly underestimated gestational age, the computer simulation predicts that 37-5% of these (that is, an additional 0/9% of the screened population) would require a dating scan before interpretation of the result was possible. As the corrected expected delivery date would not be within the range of those initially reported this group would require a new risk to be calculated by the laboratory. The discrepancy of dates may not become obvious until the time of the routine anomaly scan, which means that fewer than 5% of women in this subgroup-that is, 0-1% of the screened population-would experience delay in being offered an amniocentesis.
Although there is as yet no general agreement on the type and number of analytes to use for screening for Down's syndrome, there seems to be evidence that the free I3 subunit of human chorionic gonadotrophin improves sensitivity and that conjugated oestriol offers little in addition to ox fetoprotein and 13 human chorionic gonadotrophin.'7 1' Combined screening for Down's syndrome and neural tube defects on the same blood sample taken at around 16 weeks is becoming technically easier."9 Both results are dependent on gestational age and could be reported together in this manner. Reducing error in gestational dating will improve detection rates in a screening programme for Down's syndrome.3 14 Our method promises to achieve this by identifying those cases which require early scanning for correct assessment of risk, without the logistical and financial burden of additional dating scans for the whole population.
